Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chotaro Onaga

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Plos One|May 23, 2022
High expression of SLC20A1 is less effective for endocrine therapy and predicts late recurrence in ER-positive breast cancerChotaro Onaga, Shoma Tamori, Izumi Matsuoka, et al.
Anticancer Research|October 26, 2022
High Expression of <i>CD58</i> and <i>ALDH1A3</i> Predicts a Poor Prognosis in Basal-like Breast CancerYuyun Xiong, Hitomi Motomura, Shoma Tamori, et al.
Anticancer Research|December 30, 2023
Luminal B Breast Cancer Coexpressing <i>p62</i> and <i>ALDH1A3</i> Is Less Susceptible to RadiotherapyAyaka Ozaki, Akari Matsuda, Yuki Maemura, et al.
Anticancer Research|January 9, 2021
High <i>SLC20A1</i> Expression Is Associated With Poor Prognoses in Claudin-low and Basal-like Breast CancersChotaro Onaga, Shoma Tamori, Hitomi Motomura, et al.
Oncology Letters|July 18, 2024
Co‑expression of <i>SLC20A1</i> and <i>ALDH1A3</i> is associated with poor prognosis, and <i>SLC20A1</i> is required for the survival of ALDH1‑positive pancreatic cancer stem cellsIzumi Matsuoka, Takahiro Kasai, Chotaro Onaga, et al.
Cancer Diagnosis & Prognosis|July 11, 2022
High SLC20A1 Expression Is Associated With Poor Prognosis for Radiotherapy of Estrogen Receptor-positive Breast CancerChotaro Onaga, Shoma Tamori, Izumi Matsuoka, et al.
Anticancer Research|January 2, 2020
High Expression of <i>c-Met</i>, <i>PKCλ</i> and <i>ALDH1A3</i> Predicts a Poor Prognosis in Late-stage Breast CancerHitomi Motomura, Yuka Nozaki, Chotaro Onaga, et al.
Plos One|July 14, 2020
High PKCλ expression is required for ALDH1-positive cancer stem cell function and indicates a poor clinical outcome in late-stage breast cancer patientsYuka Nozaki, Hitomi Motomura, Shoma Tamori, et al.
Cancer Diagnosis & Prognosis|July 5, 2023
High <i>SLC20A1</i> Expression Indicates Poor Prognosis in Prostate CancerTaiki Okamoto, Chotaro Onaga, Izumi Matsuoka, et al.
Anticancer Research|December 1, 2021
GLO 1 and PKCλ Regulate ALDH1-positive Breast Cancer Stem Cell SurvivalHitomi Motomura, Shoma Tamori, Masa-Aki Yatani, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Plos One|May 23, 2022
High expression of SLC20A1 is less effective for endocrine therapy and predicts late recurrence in ER-positive breast cancerChotaro Onaga, Shoma Tamori, Izumi Matsuoka, et al.
Anticancer Research|October 26, 2022
High Expression of <i>CD58</i> and <i>ALDH1A3</i> Predicts a Poor Prognosis in Basal-like Breast CancerYuyun Xiong, Hitomi Motomura, Shoma Tamori, et al.
Anticancer Research|December 30, 2023
Luminal B Breast Cancer Coexpressing <i>p62</i> and <i>ALDH1A3</i> Is Less Susceptible to RadiotherapyAyaka Ozaki, Akari Matsuda, Yuki Maemura, et al.
Anticancer Research|January 9, 2021
High <i>SLC20A1</i> Expression Is Associated With Poor Prognoses in Claudin-low and Basal-like Breast CancersChotaro Onaga, Shoma Tamori, Hitomi Motomura, et al.
Oncology Letters|July 18, 2024
Co‑expression of <i>SLC20A1</i> and <i>ALDH1A3</i> is associated with poor prognosis, and <i>SLC20A1</i> is required for the survival of ALDH1‑positive pancreatic cancer stem cellsIzumi Matsuoka, Takahiro Kasai, Chotaro Onaga, et al.
Cancer Diagnosis & Prognosis|July 11, 2022
High SLC20A1 Expression Is Associated With Poor Prognosis for Radiotherapy of Estrogen Receptor-positive Breast CancerChotaro Onaga, Shoma Tamori, Izumi Matsuoka, et al.
Anticancer Research|January 2, 2020
High Expression of <i>c-Met</i>, <i>PKCλ</i> and <i>ALDH1A3</i> Predicts a Poor Prognosis in Late-stage Breast CancerHitomi Motomura, Yuka Nozaki, Chotaro Onaga, et al.
Plos One|July 14, 2020
High PKCλ expression is required for ALDH1-positive cancer stem cell function and indicates a poor clinical outcome in late-stage breast cancer patientsYuka Nozaki, Hitomi Motomura, Shoma Tamori, et al.
Cancer Diagnosis & Prognosis|July 5, 2023
High <i>SLC20A1</i> Expression Indicates Poor Prognosis in Prostate CancerTaiki Okamoto, Chotaro Onaga, Izumi Matsuoka, et al.
Anticancer Research|December 1, 2021
GLO 1 and PKCλ Regulate ALDH1-positive Breast Cancer Stem Cell SurvivalHitomi Motomura, Shoma Tamori, Masa-Aki Yatani, et al.
Pageof 2